Xenogeneic transplantation: A review

Transplantation

Volumn 46, Issue 1, 1988, Pages 1-20

  Auchincloss, Hugh ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN; THYMOCYTE ANTIBODY;

ANTIGEN PRESENTATION; CELLULAR IMMUNITY; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; XENOGRAFT;

ANIMAL; GRAFT SURVIVAL; HUMAN; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HETEROLOGOUS;

EID: 0023683392     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-198807000-00001     Document Type: Article

References (356)

1. Council on Scientific Affairs. Xenografts: review of the literature and current status. JAMA 1985; 254: 3353.
2. Hardy MA, Todd G, Reemtsma K. In: Slavin S, ed. Bone marrow and organ transplantation. Amsterdam: Elsevier Science, 1984.
3. Rapaport FT. Spare parts revisited. Transplant Proc 1975; 7:343.
4. Dubernard JM, Bonneau M, Latour M. Heterografts in primates. Villeurbanne, France: Fondation Merieux, 1974.
5. Hammer C, Chaussy C, Krebs G, Fiedler H, Pongratz H, Brendel W. A new concept for classification of xenograft rejection. Eur Surg Res 1973; 5: 19.
6. Shons AR, Moberg AW, Najarian JS. In: Najarian JS, Simmons R, eds. Transplantation. Philadelphia: Lea & Febiger, 1972.
7. Hersh EM. Blastogenic responses of human lymphocytes to xenogeneic cells in vitro. Transplantation 1971; 12: 287.
8. Lance EM. Response of mice to xenografts of skin. Transplant Proc 1970; 2: 497.
9. Reemtsma K. Heterotransplantation. Transplant Proc 1969; 1: 251.
10. Calne RY. Organ transplantation between widely disparate species. Transplant Proc 1970; 2: 550.
11. Hager EB. The Forssman antigen as a model for the study of homograft and heterograft immunity. Transplantation 1967; 5: 1436.
12. Reemtsma K. Renal heterotransplantation from nonhuman primates to man. Ann NY Acad Sci 1969; 162: 412.
13. Deodhar SD. Review of xenografts in organ transplantation. Transplant Proc 1986; 18: 83.
14. Pierson RN III, Rose EA. Cardiac xenografting In: Baumgartner W, Reitz BA, eds. Cardiac surgery, (in press).
15. Reemtsma K, McCracken BH, Schlegel JV, Pearl MA, Dewitt CW, Creech O Jr. Reversal of early graft rejection after renal heterotransplantation in man. JAMA 1964; 187: 691.
16. Reemtsma K, McCracken BH, Schlegel JU, et al. Renal hetero transplantation in man. Ann Surg 1964; 160: 384.
17. Reemtsma K, McCracken BH, Schlegel JV, Pearl M. Heterotransplantation of the kidney: two clinical experiences. Science 1964; 143: 700.
18. Hitchcock CR, Riser JC, Telander RL, Seljeskob EL. Baboon renal grafts. JAMA 1964; 189: 934.
19. Ogden DA, Sitprija V, Holmes JH. Function of the baboon renal heterograft in man and comparison with renal homograft function. J Lab Clin Med 1965; 65: 370.
20. Starzl TE. Experiences in renal transplantation. Philadelphia: Saunders, 1964.
21. Starzl TE, Marchioro TL, Peters GN, et al. Renal heterotransplantation from baboon to man: experience with six cases. Transplantation 1964; 2: 752.
22. Porter KA, Marchioro TL, Starzl TE. Pathological changes in six treated baboon to man renal heterotransplants. Br J Urol 1965; 37: 274.
23. Hardy JD, Chavez CM. The first heart transplant in man. Am J Cardiol 1968; 22: 772.
24. Hardy JD, Chavez CM, Kurrus FD, et al. Heart transplantation in man: developmental studies and report of a case. JAMA 1964; 188:1132.
25. Starzl TE, Ishikawa M, Putnam CW, et al. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc 1974; 6: 129.
26. Giles GR, Boehmig HJ, Amemiya H, Halgrimson CG, Starzl TE. Clinical heterotransplantation of the liver. Transplant Proc 1970; 2: 506.
27. Starzl TE. Experience in hepatic transplantation. Philadelphia: Saunders, 1969.
28. Barnard CN, Wolpowitz A, Losman JG, et al. Heterotopic cardiac transplantation with a xenograft for assistance of the left heart in cardiogenic shock after cardiopulmonary bypass. S Afr Med J 1978; 52: 1035.
29. Walpoth BH, Nehlsen-Cannarella SL, Bailey LL. Xenotransplantation: extended indications for pediatric cardiac transplantation. Transplant Proc 1986; 18(suppl 3): 43.
30. Bailey LL, Nehlsen-Cannarella SL, Concepcion W, Jolley WB. Baboon-to-human cardiac xenotransplantation in a neonate. JAMA 1985; 254: 3321.
31. Dewitt CW, Reemtsma K, Oliver CB, Ahlschier A. In: Dausset J, Hanburger J, Mathe G, eds. Advances in transplantation. Baltimore: Williams & Wilkins, 1968; 409.
32. Dewitt CW. Serologic response of human to chimpanzee tissue. Fed Proc 1965; 24: 573.
33. Dewitt CW, Huber HJ, Moor-Jankowski J, Shukman NR, Weiner AS. Some immunological aspects of homo and heterotransplantation in man and other primates. Bibl Haemat 1965; 23: 213.
34. Rollands DT, Kirkpatrick CH, Vatter AE, Wilson WEC. Immunologic studies in human organ transplantation: IV. Serologic and pathologic studies following heterotransplantation of the kidney. Am J Pathol 1967; 50: 605.
35. Hume DM, Gayle WE Jr, Williams GM. Cross circulation of patients in hepatic coma with baboon partners having human blood. Surg Gynecol Obstet 1969; 128: 495.
36. Ham JM, Pirola RC, Davidson GM, Yarrow S, Elmsliz RG. Pig liver perfusion for the treatment of acute hepatic coma. Surg Gynecol Obstet 1968; 127: 453.
37. Abouna GM. Cross-circulation between man and baboon in hepatic coma. Lancet 1968; 2: 729.
38. Saunders SJ, Bosman SCW, Walls R, et al. Acute hepatic coma treated by cross-circulation with a baboon and by repeated exchange transfusions. Lancet 1968; 2: 585.
39. Bosman SCW, Saunders SJ, Terblanche J, Harrison GG, Barnard CN. Cross circulation between man and baboon. Lancet 1968; 2: 583.
40. Eiseman B. Cross circulation in heterologous systems. Colston Papers 1967; 279.
41. Norman JC, Saravis CA, Brown ME, McDermott WV Jr. Immunochemical observations in clinical heterologous (xenogeneic) liver perfusions. Surgery 1966; 60: 179.
42. Bibler DD, Condon RE, Nyhus LM. Active sensitization from heterologous liver perfusion. Bull Soc Int Chir 1966; 25: 671.
43. Eiseman B, Liem DS, Raffucci F. Heterologous liver perfusion in treatment of hepatic failure. Ann Surg 1965; 162: 329.
44. Hume DM, Magee JH, Kaufman HM, Rittenbury MS, Prout GR Jr. Renal homotransplantation in man in modified recipients. Ann Surg 1964; 158: 608.
45. Liem DS, Waltuch TL, Eiseman B. Function of the ex-vivo pig liver perfused with human blood. Surg Forum 1964; 15: 90.
46. Eiseman B, Knipe P, McColl HA, Orloff MJ. Isolated liver perfusion for reducing blood amonia. Arch Surg 1961; 83: 356.
47. Abouna GM, Fisher LM, Still WJ, Hume DM. Acute hepatic coma successfully treated by extracorporeal baboon liver perfusion. Br Med J 1972; 1: 23.
48. Abouna GM, Ashcroft T, Muckle TJ, et al. Heterologous extracorporeal hepatic support: hemodynamic, biochemical and immunological observation. Br J Surg 1970; 57: 213.
49. Veatch RM. The ethics of xenografts. Transplant Proc 1986; 18: 93.
50. Jonasson O, Hardy MA. The care of Baby Fae [Editorial], JAMA 1985; 254: 3358.
51. Caplan AL. Ethical issues raised by research involving xenografts. JAMA 1985; 254: 3339.
52. Capron AM, Regan T, Reemtsma K, et al. The subject is Baby Fae. Hastings Center Rep 1985; 15: 8.
53. Rosner F. Medical ethics of Judaism regarding Baby Fae. Arch Intern Med 1985; 145: 1330.
54. Veatch RM. Medical ethics re xenografting? Am J Law Med 1984; 9: 427.
55. Douglas JD. Suitability and availability of chimpanzees as organ donors for man. Transplant Proc 1970; 2: 539.
56. Woodruff M. Summary. Transplant Proc 1970; 2: 557.
57. Terasaki PI, Marchioro TH, Starzl TE. In: Amos DB, ed. Workshop on Council, Washington, DC, 1964: 83.
58. Starzl T. Experience in renal transplantation. Philadelphia: Saunders, 1970.
59. Kissmeyer-Nielson F, Olsen S, Peterson VP, Fjeldborg O. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet 1966; 2: 662.
60. Toth I, Roth E, Szmolensky S, Pasca S, Torok B. Characteristics of hyperacute rejection of swine kidney xenografts perfused with canine blood. Int Urol Nephrol 1976; 8: 323.
61. Rosenberg JC, Broersma RJ, Bullemer G, Mammen EF, Lenaghan R, Rosenberg BF. Relationship of platelets, blood coagulation, and fibrinolysis to hyperacute rejection of renal xenografts. Transplantation 1969; 8: 152.
62. Belitsky P, Popovtzer MM, Smith JA, Katz F. Renin-angiotensin activation in hyperacute renal xenograft rejection. Proc Soc Exp Biol Med 1974; 145: 11922.
63. Rosenberg JC, Hawkins E, Rector F. Mechanisms of immunological injury during antibody-mediated hyperacute rejection of renal heterografts. Transplantation 1971; 11: 151.
64. Yoshioka H, McCalmon RT, Putnam CW, Mcintosh RM, Ter- man DS. Attenuation of hyperacute xenograft rejection in unmodified host by extracorporeal plasma perfusion. Transplantation 1977; 24: 78.
65. Linn BS, Jensen JA, Pardo V, Davies D, Franklin L. Relationship between structural and functional changes in rejecting renal xenografts. Transplant Proc 1971; 3: 527.
66. Shons AR, Bier M, Jetzer T, Najarian JS. Techniques of in vivo plasma modification for the treatment of hyperacute rejection. Surgery 1973; 73: 28.
67. Moberg AW, Shons AR, Gewurz H, Mozes M, Najarian JS. Prolongation of renal xenografts by the simultaneous sequestration of preformed antibody, inhibition of complement, coagulation, and antibody synthesis. Transplant Proc 1971; 3: 538.
68. Bier M, Beavers CD, Merriman WG, Merkel FK, Eiseman B, Starzl TE. Selective plasmapheresis in dogs for delay of heter- ograft response. Trans Am Soc Art Intern Organs 1970; 16: 325.
69. Shons AR, Jetzer J, Moberg AW, Najarian JS. Prolongation of heterograft survival by electrophoretic extraction of preformed antibody. Surg Forum 1970; 21: 263.
70. Shons AR, Najarian JS. Modification of xenograft rejection by aspirin, dextran, and cinanserin: the importance of platelets in hyperacute rejection. Transplant Proc 1974; 6: 435.
71. Bittscheidt H, Vahlensieck W, Sobbe A. Circulation time in xenogeneic renal grafts. Urol Int 1973; 28: 220.
72. Kashii A, Derry CD, Lafortune L, et al. The effect of modification of coagulation factors on xenograft rejection. Surg Forum 1971; 22: 242.
73. Slapak M, Greenbaum M, Bardawil W, Saravis C, Joison J, McDermott WV. Effect of heparin, arvin, liver perfusion, and heterologous antiplatelet serum on rejection of pig kidney by dog. Transplant Proc 1971; 3: 558.
74. Kux M, Boehmig HJ, Amemiya H, et al. Modification of hyperacute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial infusion of citrate. Surgery 1971; 70: 103.
75. Hawkins E, Mammen E, Rosenberg JC. Effects of heparin and steroids on hyperacutely rejected renal xenografts. J Surg Res 1971; 11: 492.
76. Linn BS, Jensen J, Pardo V, Levi DF, Hutson DG. Prolongation of renal xenografts by citrate. JAMA 1970; 212: 864.
77. Messmer K, Hammer C, Land W, et al. Modification of hyperacute xenogeneic kidney rejection. Transplant Proc 1971; 3: 542.
78. Kux M, Boehmig HJ, Torisu M, et al. Modification of pig to dog renal xenograft rejection by the intraarterial infusion of citrate. Soc Univ Surg 1970; 32: 33.
79. Jensen JA. A specific inactivator of mammalian C4 isolated from nurse shark (Ginglistoma cirratum) serum. J Exp Med 1969; 130: 217.
80. Snyder GB, Ballesteros E, Zarco RM, Linn BS. Prolongation of renal xenografts by complement suppression. Surg Forum 1966; 17: 478.
81. Habal MB, Misra MK, Busch GJ, Carpenter CB, Birtch AG. The renal xenograft rejection: effect of hyperimmune F(ab')2 and succinylated IgG. Transplantation 1973; 14: 796.
82. Hammer C, Land W, Brendel W. Experimental xenotransplantation in widely divergent species: mechanism of the xenogeneic hyperacute rejection, their modification under the influence of active and passive enhancement. Res Exp Med 1973; 159: 239.
83. Winn BS, Jensen JA, Portal P, Snyder GB. Renal xenograft prolongation by suppression of natural antibody. J Surg Res 1968; 8: 211.
84. Hammer C, Fiedler L, Klouekorn W, Land W, Messmer K, Brendel W. Mitigation of the hyperacute xenogeneic rejection of kidneys in widely divergent species. Eur Surg Res 1970; 2: 112.
85. Makowka L, Miller C, Chapchap P, et al. Prolongation of pig-to- dog renal xenograft survival by modification of the inflammatory mediator response. Ann Surg 1987; 206: 482.
86. Jorgensen KA, Kemp E, Barfort P, et al. The survival of pig to rabbit renal xenografts during inhibition of thromboxane synthesis. Thromb Res 1983; 32: 585.
87. Merkel FK, Bier M, Beavers CD, Merriman WG, Wilson C, Starzl TE. Modification of xenograft response by selective plasmapheresis. Transplant Proc 1971; 3: 534.
88. Nelson RA. A new concept of immunosuppression in the hypersensitivity reactions and in transplantation immunity. Surv Ophthalmol 1966; 11: 498.
89. Perper RJ, Najarian JS. Experimental renal heterotransplantation: I. In widely divergent species. Transplantation 1966; 4: 377.
90. Bier M, Zukoski CF, Boyer JT, Beavers CD, Merriman WG. Delay of xenograft rejection through oxidation of blood during hemodialysis. Trans Am Soc Art Intern Organs 1971; 17: 64.
91. Clark DS, Foker JE, Pickering R, Good RA, Varco RL. Evidence for two platelet populations in xenograft rejection. Surg Forum 1966; 17: 264.
92. Hammer C, Chaussy C, Krebs G, von Scheel J, Brendel W. Experimental xenogeneic kidney transplantation in closely related species: ex vivo hemoperfusion of kidney in the system cat (donor) to dog (recipient). Res Exp Med (Berl) 1973; 160: 32.
93. Chaussy C, Hammer C, von Scheel J, Eisenherger F, Pielsticker K, Brendel W. Experimental xenogeneic kidney transplantation in closely related species: transplantation of cat kidneys to untreated and sensitized dogs. Res Exp Med (Berl) 1973; 159: 266.
94. Chaussy C, Hammer C, Eisenberger F, Pielsticker K, Brendel W. Experimental xenografting in closely related species (cat-dog). Urol Int 1973; 28: 230.
95. Chaussy C, Hammer C, Eisenberger F, et al. Some aspects of the rejection of xenogeneic kidney transplants in different donor recipient combinations. Eur Surg Res 1972; 4: 262.
96. Mundy AR. Prolongation of cat to dog renal xenograft survival with prostacyclin. Transplantation 1980; 30: 226.
97. Rattazzi L, Haimov MN, Glabman S, Papatestas A, Glabman S, Burrows L. Role of the platelet in the obliteration vascular transplant rejection phenomenon. Surg Forum 1970; 21: 241.
98. Kemp E, Kemp G, Abildgaard-Jacobsen I, Lundborg C. Prolongation of survival of renal xenografts by infusion of donor blood. Acta Pathol Microbiol Scand [A] 1977; 85: 267.
99. Cameron DJ, Rajagopalan PR, Fitts CT, Majeski JA. Characterization of the preformed antibodies involved in the xenograft reaction. J Surg Oncol 1983; 22: 157.
100. Mejia-Lagun JE, Martinez-Palomo A, Biro CE, Chavez B, Lopez- Soriano F, Garcia-Cornejo M. Morphologic study of the participation of the complement system in hyperacute rejection of renal xenografts. Am J Pathol 1972; 69: 71.
101. Mejia-Laguna JE, Martinez-Palomo A, Lopez-Soriano F, Garcia- Cornejo M, Biro CE. Prolonged survival of kidney xenografts in leukopenic rabbits. Immunology 1971; 21: 879.
102. Owen ER. Xenograft protection by low dose, antigen-induced tolerance. Transplant Proc 1971; 3: 562.
103. Owen ER. Prolonged survival in heterografted kidneys with transplantation antigen pretreatment. Nature 1968; 219: 970.
104. Owen ER. Prolonged survival in heterografted kidneys with transplant antigen pretreatment. Nature 1968; 219: 970.
105. Sakai K, Kountz SL. Dissociation of humoral and cellular immune reactions of the rabbit, guinea pig, and dog kidney xenografts in the rat. J Surg Res 1976; 21: 159.
106. Perper RJ. Renal heterotransplant rejection: a model for separation of humoral and cellular mechanisms. Transplantation 1971; 12: 519.
107. Gunnarson A, Moberg AW, Gewurz H, Perper RJ, Najarian JS. Synergistic effects of cytosine arabinoside combined with anti- lymphocyte globulin for suppressing xenograft rejection. Surg Forum 1969; 20: 263.
108. Perper RJ, Najarian JS. Experimental renal heterotransplantation: III. Passive transfer of transplantation immunity. Transplantation 1967; 5: 514.
109. Moses MF, Gewurz H, Gunnarson A, et al. Xenograft rejection by dog and man: isolated kidney perfusion with blood and plasma. Transplant Proc 1971; 3: 531.
110. Hammer C, Land W, Pielsticker K, Brendel W. Experimental xenografting in widely divergent species: modification of the hyperacute xenogeneic rejection of organ by long term immunization of dogs (recipient) with complete liver-homogenate from sheep (donor). Res Exp Med (Berl) 1973; 159: 124.
111. Ghilchik MW, Morris AJ. Platelet trapping by sheep kidney and heart xenografts in dogs. J Surg Res 1974; 17: 434.
112. Ghilchik MW, Morris AS. Modification of hyperacute rejection of sheep kidney heterografts in the dog using a trysin inhibitor. Nature 1971; 233: 557.
113. Jorgensen KA, Kemp E, Barfort P, Starklint H, Larsen S, Munk- Andersen G. Platelet aggregation is not essential for xenograft rejection. Thromb Res 1986; 43: 87.
114. Clark DS, Gewurz H, Good RA, Varco RL. Complement fixation during homograft rejection. Surg Forum 1964; 15: 144.
115. Gewurz H, Clark DS, Cooper MD, Varco RL, Good RA. Effect of cobra venom-induced inhibition of complement activity on allograft and xenograft rejection reactions. Transplantation 1967; 5: 1296.
116. Kemp E, Kemp G, Starklint H, Larsen S. Immunosuppression with cobra venom factor, anti-platelet aggregator, and cyclosporin A in renal xenotransplantation. Transplant Proc 1982; 14: 116.
117. Kemp E, White D, Dieperink H, Larsen S, Starklint H, Steinbru- chel D. Delayed rejection of rabbit kidneys transplanted into baby pigs. Transplant Proc 1987; 19:1143.
118. Kemp E, Kemp G, Svendsen P, Nielsen E, Buhl MR. Prolongation of xenograft survival by infusion of heterologous antibodies against recipient serum. Acta Pathol Microbiol Scand 1976; 84C: 342.
119. Chavez-Peon F, Monchik G, Winn HJ, Russell PS. Humoral factors in experimental renal allograft and xenograft rejection. Transplant Proc 1971; 3: 573.
120. Schilling A, Land W, Pratschke E, Pielsticker K, Brendel W. Dominant role of complement in the hyperacute xenograft rejection reaction. Surg Gynecol Obstet 1976; 142: 29.
121. Dubernard JM, Bonneau M, Bomel J, et al. Renal and skin xenografts from baboon to macques: effect of antilymphocyte globulins. Transplant Proc 1971; 3: 545.
122. Mowbray JF, Kenyon JR. An experimental study on the action of 5-hydroxytryptamine antagonists on the recently transplanted renal allograft, homograft, and heterograft. Bull Soc Int Chir 1961; 20: 604.
123. Weil R, Nozawa M, Weber C, et al. Cardiac heterotransplantation: morphological and immunohistological studies. Transplantation 1975; 19: 150.
124. Cattell V, Jamieson SW. Hyperacute rejection of guinea pig to rat cardiac xenografts: I. Morphology. J Pathol 1975; 115: 183.
125. Jamieson SW. Xenograft hyperacute rejection: a new model. Transplantation 1974; 17: 533.
126. Zhang J, Munda R, Glas-Greenwalt P, Weiss MA, Pollak VE, Alexander JW. Prolongation of survival of a heart xenograft by defibrination with ancrody. Transplantation 1983; 35: 620.
127. Adachi H, Rosengard BR, Hutchins GM, et al. Effects of cyclosporin, aspirin, and cobra venom factor on discordant cardiac xenograft survival in rats. Transplant Proc 1987; 19: 1145.
128. Settaf A, Meriggi F, Van de Stadt J, et al. Delayed rejection of liver xenografts compared to heart xenografts in rats. Transplant Proc 1987; 19: 1155.
129. Silberman H, Reckard CR, Klinman N, Barker CF. Dependence of antilymphocyte serum effectiveness on degree of donor-recip- ient histocompatibility. Surg Forum 1972; 23: 303.
130. Rosengard BR, Adachi H, Veda K, et al. Differences in the pathogensis of first-set allograft rejection and acute xenograft rejection as determined by sequential morphologic analysis. J Heart Tx 1986; 5: 263.
131. Rosengard BR, Hall TS, Imagawa DK, et al. Hyperacute rejection of cardiac xenografts: two new models showing differences in pathogenesis. Surg Forum 1985; 36: 361.
132. Chartrand C, O'Regan S, Robitaille P, Pinto-Blonde M. Delayed rejection of cardiac xenografts in C6-deficient rabbits. Immunology 1979; 38: 245.
133. Lexer GH, Cooper DKC, Wicomb WN, et al. Cardiac transplantation using discordant xenografts in a nonhuman primate model. Transplant Proc 1987; 19: 1153.
134. Baldamus CA, McKenzie IFC, Winn HJ, Russell PS. Acute destruction by humoral antibody of rat skin grafted to mice. J Immunol 1973; 110: 1532.
135. Baldamus CA, Winn HJ, Russell PS. Acute rejection of skin xenografts in the mouse after passive transfer of humoral antibody. Fed Proc 1970; 29: 785.
136. Winn HJ, Baldamus CA, Jooste SV, Russell PS. Acute destruction by humoral antibody of rat skin grafted to mice: the role of complement and polymorphonuclear leukocytes. J Exp Med 1973; 137: 893.
137. Hamilton DNH, Gaugus JM. Humoral and cellular factors in xenograft rejection by mice. Transplantation 1972; 13: 620.
138. Bogman MJJTh, Berden JHM, Hagemann JFHM, Maass CN, Koene RAP. Patterns of vascular damage in the antibody- mediated rejection of skin xenografts in the mouse. Am J Pathol 1980; 100: 727.
139. Hasek M. Abolition of tolerance of skin heterografts by means of serum antibodies. Folia Biol (Praha) 1962; 8: 57.
140. Ben-hur N, Solowey AC, Rapaport FT. Xenograft rejection phenomenon: I. Response of the mouse to rabbit, guinea pig and rat skin xenografts. Israel J Med Sci 1969; 5: 1.
141. Ben-hur N, Solowey AC, Rapaport FT. The xenograft rejection phenomenon: II. Response of the guinea pig to mouse, rat and rabbit xenografts. Israel J Med Sci 1969; 5: 322.
142. Pepin J, Eto K, Howard JM, Pairent PW. Heterotransplantation of the pancreatic islet cell mass from sheep to dogs. Arch Surg 1968; 97: 118.
143. Speiller PB, Kikkawa Y, Joseph J, Veith FJ, Cook WA. Steroid attenuation of hyperacute pulmonary xenograft rejection. Rev Surg 1973; 30: 222.
144. Speiller PB, Kikkawa Y, Veith FJ, Cook WA. Steroid protection of a pulmonary xenograft model. Surg Forum 1972; 23: 272.
145. Frangipane LG, Poole TW, Barker CF, Silvers WK. Vulnerability of allogeneic and xenogeneic islets to alloantisera. Transplant Proc 1977; 9: 371.
146. Naji A, Reckard CR, Ziegler MM, Barker CF. Vulnerability of pancreatic islets to immune cells and serum. Surg Forum 1975; 26: 459.
147. Perloff LJ, Naji A, Barker AF. Islet sensitivity to humoral antibody. Surg Forum 1981; 32: 390.
148. Chaussy C, Hammer C, Pongratz H, et al. Prolongation of graft survival in rats and dogs by a specific antimacrophage serum (AMS). Transplant Proc 1975; 7: 779.
149. Steinbruchel D, Kemp E, Starklint H, Dieperink H. Synergistic effect of cyclosporine A, cyclophosphamide, and steroids in rabbit-to-rat skin xenotransplantation. Transplant Proc 1987; 19:1168.
150. Calne RY. Observations on renal homotransplantation. Br J Surg 1961; 48: 384.
151. Gordon RD, Iwatsuki S, Asquivel CO, Tzakis A, Todo S, Starzl TE. Liver transplantation across ABO blood groups. Surgery 1986; 100: 342.
152. Starzl TE, Iwatsuki S, Van Thiel DH, et al. Evolution of liver transplantation. Hepatology 1982; 2: 614.
153. Gordon RD, Fung JJ, Markus B, et al. The antibody crossmatch in liver transplantation. Surgery 1986; 100: 705.
154. Knechtle SJ, Kolbeck PC, Tsuchimoto S, Coundouriotis A, San- filippo F, Bollinger RR. Hepatic transplantation into sensitized recipients: demonstration of hyperacute rejection. Transplantation 1987; 43: 8.
155. Staines NA. Relative immunogenicity of H-2 and other membrane components in xenoimmunization. Transplantation 1974; 17: 470.
156. Metzgar RS, Seigler HF. Tissue antigens of man and chimpanzees: their role in xenografting. Transplant Proc 1970; 2: 463.
157. Balner H, van Leeuwen A, van Vreeswizk W, Dersjant H, van Rood JJ. Leukocyte antigens of chimpanzees and their relation to human HL-A antigens. Transplant Proc 1970; 2: 454.
158. Dorf ME, Eguro SY, Amos DB. Cross-reaction of HL-A antibodies: IV. Absorption and elution with primate platelets. Transplant Proc 1972; 4: 71.
159. Etheredge EE, Shons AR, Najarian JS. Accelerated skin allograft rejection following xenogeneic sensitization. Transplant Proc 1971; 3: 1585.
160. Manning DD, Reed ND, Shaffer CF. Maintenance of skin xenografts of widely divergent phylogenetic origin on congenitally athymic (nude) mice. J Exp Med 1973; 138: 488.
161. Miller JFAP. In: Wolstenholme GEW, Cameron MP, eds. Ciba Foundation Symposium on Transplantation 1962; 384.
162. Usadel KH, Schwedes U, Bastert G, et al. Transplantation of human fetal pancreas: experience in thymus aplastic mice and rats and in a diabetic patient. Diabetes 1981; 29: 74.
163. Usadel KH, Bastert B, Schwedes U, Obert I, Forteyer HP, Schof- fliny K. Human fetal pancreas transplants in nu/nu mice. Lancet 1977; 1: 365.
164. Leclerc M, Panijel J, Toyama K. Heterotransplantation of invertebrate organs to congenitally athymic mice. Transplantation 1975; 19: 74.
165. Povlsen CO, Skakkeback NE, Rygaard J, Jensen B. Heterotransplantation of human fetal organs to the mouse mutant nude. Nature 1974; 248: 247.
166. Tuch BE, Grigoriou S, Turtle JR. Comparison of liver, spleen, and kidney as sites for xenografting human fetal pancreas in the nude mouse. Transplant Proc 1987; 19: 2907.
167. Tuch BE, Grigoriou S, Turtle JR. Diabetes 1986; 35: 464.
168. Hullett DA, Falany JL, Love RB, Burlingham WJ, Pan M, Sol- linger HW. Human fetal pancreas: a potential source for transplantation. Transplantation 1987; 43: 18.
169. Taguchi O, Takahashi T, Seto M, Namikawa R, Matsuyama M, Nishizuka Y. Development of multiple organ-localized autoimmune diseases in nude mice after reconstitution of T cell function by rat fetal thymus graft. J Exp Med 1986; 164: 60.
170. Monaco AP, Wood ML, Gray JG, Russell PS. Studies on heterologous anti-lymphocyte serum in mice: effect on the immune response. J Immunol 1966; 96: 229.
171. Jooste SV, Colvin RB, Winn HJ. The vascular bed as the primary target in the destruction of skin grafts by antiserum: 2. Loss of sensitivity to antiserum in long-term xenografts of skin. J Exp Med 1981; 154: 1332.
172. Cerilli J, Gideon L, Hattan D. Effect of immunosuppression and cellular antigen on xenograft survival. Transplant Proc 1970; 2: 516.
173. Lance EM, Medawar PB. Survival of skin heterografts under treatment with antilymphocyte serum. Lancet 1968; 1: 1174.
174. Chen CMC, Tsai LC, Chung CF, Han SH. Survival times of skin xenografts in mice under chronic treatment with antithymocyte serum in different dosage-timing schedules. Transplantation 1971; 12: 157.
175. Perper RJ, Monovich RE, Bowersox BE. Long-term skin allograft survival elicited by a finite treatment with anti-lymphocyte serum combined with cytarabine. J Immunol 1970; 104: 1063.
176. Shaffer CF. Transfer of immunity against long surviving rat skin xenografts by antilymphocyte serum treated Syrian hamster. Nature 1969; 223: 1375.
177. Duswald KH, Scheel JV, Hammer C, Brendel W. Long-term graft survival in the xenogeneic system wolf-dog. Res Exp Med (Berl) 1976; 167: 255.
178. Lance EM, Medawar PB. Immunosuppressive effects of heterologous antilymphocyte serum in monkeys. Lancet 1970; 1: 167.
179. Donawick WJ, Shaffer CF, Dodd DC, Buchanan JW, Fregin GF. Cardiac and skin heterograft rejection: suppression with antilymphocyte serum. Transplant Proc 1971; 3: 551.
180. Brendel W, Duswald KH, von Scheel J, Chaussy C, Sollinger HW, Hammer C. Prolonged survival time of canine xenografts using a new schedule of horse anti-dog lymphocyte globulin (ALG) therapy. Transplant Proc 1978; 9: 379.
181. Marquet RL, van Es AA, Heystek GA, van Leersum RH, Balner H. Prolongation of baboon to rhesus monkey kidney xenograft survival by pre-transplant rhezus blood transfusion. Transplantation 1978; 25: 165.
182. Chabot J, Weber C, Hardy MA, et al. Synergy of ALS and UV-B in prolongation of primate-to-mouse islet xenograft survival. Transplant Proc 1987; 19: 1160.
183. Lacy PE, Davie J, Finke EH. Prolongation of islet xenograft survival (rat to mouse). Diabetes 1981; 30: 285.
184. Lacy PE, Davie J, Finke EH. Prolongation of islet xenograft survival without continuous immunosuppression. Science 1980; 209: 283.
185. Selawry H, Whittington K, Fajaco R. Effect of cyclosporine on islet xenograft survival in the BB/W rat. Transplantation 1986; 42: 568.
186. Janney CG, Lacy PE, Finke EH, Davie JM. Prolongation of intrasplenic islet xenograft survival. Am J Pathol 1982; 107:1.
187. Burdick JF, Russell PS, Winn HJ. Sensitivity of long-standing xenografts of rat hearts to humoral antibodies. J Immunol 1979; 123:1732.
188. Burdick JF, Jooste SV, Winn HJ. Variations in the responses of mouse strains to rat xenografts. J Immunol 1979; 123: 954.
189. Jooste SV, Winn HJ. Strain variation in the responses of mice to xenografts of skin. Transplant Proc 1977; 9: 375.
190. Hardy MA, Oluwole S, Fawwaz R, Satake K, Nowygrod R, Reemtsma K. Selective lymphoid irradiation: III. Prolongation of cardiac xenografts and allografts in presensitized rats. Transplantation 1982; 33: 237.
191. Dieperink H, Steinbruchel D, Starklint H, Larsen S, Kemp E. Improvement in hare-to-rabbit kidney transplant survival. Transplant Proc 1987; 19: 1140.
192. Kemp E, Starklint H, Larsen S, Dieperink H. Cyclosporine in concordant renal hare-to-rabbit xenotransplantation: prolongation and modification of rejection, and adverse effects. Transplant Proc 1985; 17: 1351.
193. Danko I, Gebhard C, Scholz S, Gokel J, Hammer C. Transplant aspiration cytology for monitoring of kidney xenograft (Wolf- Dog) under cyclosporin A treatment. Eur J Res 1983; 15: 276.
194. Selawry H, Whittington K, Fajaco R. Effects of cyclosporine on islet xenograft survival in the BB/W rat. Transplantation 1986; 42: 568.
195. Nakajima Y, Kessler M, Nakano H, Lie TS. Restoration of T cell responsiveness to IL-2 in recipients of pancreatic islet xenografts treated with CsA. Transplantation 1985; 40: 73.
196. Sugimoto K, Shelby J, Corry RJ. Effects of cyclosporine and blood transfusion on cardiac xenografts in combination of rat and mouse. Nippon Geka Gakkai Zasshi 1985; 86:1444.
197. Homan WP, Williams KA, Fabre JW, Millard PR, Morris PJ. Prolongation of cardiac xenograft survival in rats receiving cyclosporin Ao. Transplantation 1981; 31: 164.
198. Knechtle SJ, Halperin EC, Bollinger RR. Cardiac xenograft survival using total lymphoid irradiation and cyclosporine. Heart Transplant 1985; 4: 605.
199. Knechtle SJ, Halperin EC, Bollinger ER. Xenograft survival in two species combinations using total-lymphoid irradiation and cyclosporine. Transplantation 1987; 43: 173.
200. Knechtle SJ, Halperin EC, Bollinger RR. Combined total lymphoid irradiation and cyclosporine promote'xenograft survival. Transplant Proc 1987; 19: 1137.
201. Valdivia LA, Monden M, Gotoh M, et al. Hepatic xenografts from hamster to rat. Transplant Proc 1987; 19: 1158.
202. Monden M, Valdivia LA, Gotoh M, et al. Hamster to rat orthotopic liver transplantation. Transplantation 1987; 43: 745.
203. Bailey LL, Jang J, Johnson W, Jolley WB. Orthotopic cardiac xenografting in the newborn goat. J Thorac Cardiovasc Surg 1985; 89: 242.
204. Kurlansky PA, Sadeghi AN, Michler RE, et al. Prolonged cardiac 193. 194. xenograft survival: a favorable comparison with allografts in primates. Curr Surg 1986; 43: 413.
205. Croy BA, Rossant J, Clark DA. Recruitment of cytotoxic cells by ectopic grafts of xenogeneic, but not allogeneic, trophoblast. Transplantation 1985; 37: 84.
206. Egdahl RH, Varco RL, Good RA. Local reactions and lymph node response to skin heterografts between rabbits and rats. Int Arch Allergy 1958; 13: 129.
207. Chaussy C, Hammer C, von Scheel J, et al. Xenogeneic skin and kidney transplants in a closely related canine system, fox-dog. Transplantation 1975; 20: 150.
208. Eisenberger F, Chaussy C, Hammer C, et al. Xenogeneic kidney transplant in closely related species (Fox-dog). Urol Int 1975; 28: 224.
209. Chaussey C, Hammer C, von Scheel, et al. Behavior of xenogeneic kidney transplants in closely related species (fox-dog). Res Exp Med (Berl) 1972; 157: 257.
210. Perper RJ, May J, Way L, Najarian JS. Experimental renal heterotransplantation in closely related species. Fed Proc 1965; 24: 573.
211. May LW, May J, Perper RJ. Experimental renal heterotransplantation in various species. Fed Proc 1965; 24: 572.
212. Hammer C, Chaussey C, Welter H, Weinbacher J, Hobel G, Brendel W. Exceptionally long survival time in xenogeneic organ transplantation. Transplant Proc 1981; 13: 881.
213. Weber C, Zatriqi A, Weil R, Mcintosh R, Hardy MA, Reemtsma K. Pancreatic islet isografts, allografts, and xenografts: comparison of morphology and function. Surgery 1976; 79: 144.
214. Kakita A, Blanchard J, Fortner JG. Hamster to rat cardiac xenografts: a useful model for transplantation studies. J Surg Res 1975; 19: 99.
215. Michler RE, McManus RP, Smith CR, Sadeghi AN, Rose EA. Technique for primate heterotopic cardiac xenotransplantation. J Med Primatol 1985; 14: 357.
216. Calne RY, White HJO, Herbertson BM, et al. Pig to baboon liver xenografts. Lancet 1968; 1: 1176.
217. Jerusalem C, vHeyde MN, Jap P, et al. Rejection phenomena in heterotopic liver homo- and heterografts. Transplant Proc 1971; 3: 554.
218. Sullivan FP, Ricordi C, Hauptfeld V, Lacy PE. Effect of low- temperature culture and site of transplantation on hamster islet xenograft survival (hamster to mouse). Transplantation 1987; 44: 465.
219. Serie JR, Hickey GE, Schmitt RV, Hegre OD. Prolongation of culture-isolated neonatal islet xenografts without immunosuppression. Transplantation 1983; 36: 6.
220. Lacy PE, Finke EH, Janney CG, Davie JM. Prolongation of islet xenograft survival by in vitro culture of rat megaislets in 95% 02. Transplantation 1982; 33: 588.
221. Thompson SC, Bowen KM, Burton RC. Role of host immunosuppression and pretransplant 95% oxygen organ culture in prolongation of fetal pancreas xenograft survival. Transplant Proc 1987; 19: 1166.
222. Sollinger HW, Burkholder PM, Rasmus WR, Bach FH. Prolonged survival of xenografts after organ culture. Surgery 1977; 81: 74.
223. Lie TS. Prolongation of allograft and xenograft survival by pre- treatment with prednisolone and donor-specific antigen. Surg Gynecol Obstet 1976; 143: 369.
224. Ballantyne DL Jr, Uhlschmid GK, Converse JM. Massive rabbit skin xenografts in rats. Transplantation 1969; 7: 274.
225. Cerilli J, Hattan D. The effect of combined immunosuppressive agents and cell-free antigen on xenograft survival. Transplantation 1972; 14: 207.
226. Jeekel J, Westbroek DL. Passive enhancement of skin heterografts. Transplant Proc 1970; 3: 714.
227. Jeekel J, de Putter C, Lameyer LDF, Westbroek DL. The survival of mouse skin and heart heterografts in rats treated with xen- ogeneic hyperimmune anti-donor antiserum. Transplantation 1974; 17: 605.
228. Rosengard BR, Hall TS, Hutchins GM, et al. Modification of the immune response to xenografts by donor and graft pretreat- ment. Transplant Proc 1986; 18: 449.
229. Hardy MA, Lau H, Weber C, Reemtsma K. Pancreatic islet transplantation: induction of graft acceptance by ultraviolet irradiation of donor tissue. Ann Surg 1984; 200: 441.
230. Steinmuller D. Cross-species transplantation in embryonic and neonatal animals. Transplant Proc 1970; 2: 438.
231. Smith CS, Pilgrim HI, Steinmuller D. The survival of skin allografts and xenografts in germ-free mice. Transplantation 1972; 13: 38.
232. Nakajima Y, Nakano H, Nakayawa K, Segawa M, Shiratori T. Effect of total lymphoid irradiation on pancreatic islet xenografts survival in rats. Transplantation 1983; 34: 98.
233. Elroy R, Haffen K, Kedinger M, Grenier JF. Chick embryo pancreatic transplants reverse experimental diabetes in rats. J Clin Invest 1979; 64: 361.
234. Watkins E Jr, Aoki A. An experimental skin xenograft system with genetic uniformity of donor tissue and hosts. Lahey Clinic Foundation Bull 1967; 16: 261.
235. Etheredge EE, Shons A, Harris N, Najarian JS. Prolongation of skin xenograft survival by L-asparaginase. Transplantation 1971; 11: 353.
236. Terasaki PI, Esail ML, Cannon JA, Longmire WP Jr. Destruction of lymphocytes in vitro by normal serum from common laboratory animals. J Immunol 1961; 87: 383.
237. Shons AR, Najarian JS. Xenograft rejection mechanisms in man. Trans Am Soc Art Intern Organs 1974; 20: 562.
238. Hammer C, Chaussy C, Brendel W. Preformed natural antibodies in animals and man. Eur Surg Res 1973; 5: 162.
239. McKenzie IFC, Stocker J, Ting A, Morris PJ. Human lympho- cytotoxic and hemagglutinating activity against sheep and pig cells. Lancet 1968; 2: 386.
240. Palutke M, Kihn R, Rosenberg JC. In vitro studies of hyperacute rejection of xenografts. Eur Surg Res 1972; 4:1.
241. Marceau JP, Hallenbeck GA, Zollman PE, Butler H, Shorter RG. A comparison of autoplastic, allogeneic and xenogeneic perfusion of isolated kidneys. J Surg Res 1965; 5: 492.
242. Land W, Schilling A, Aldenhoff J, et al. In vitro studies on the mechanism of hyperacute xenograft rejection. Transplant Proc 1971; 3: 888.
243. Terasaka R, Nomoto K, Himento K, Takeya T. Relationships among differentiated T-cell subpopulations; IV. Preferential induction of delayed footpad reaction to xenografts and its radioresistant nature. Immunology 1981; 36: 699.
244. Newlands ES, Roitt IM. Evidence for two cell populations involved in the rejection of a xenograft in mice. Transplantation 1975; 20: 13.
245. Dennert G. Effector mechanisms of cell-mediated immunity to xenogeneic cell antigens. J Immunol 1974; 113: 201.
246. Harding B, MacLennan ICM. The distribution of antibody and antibody-producing cells after immunization with xenogeneic cells. Immunology 1972; 23: 35.
247. Moller G, Svehag SE. Specificity of lymphocyte-mediated cytotoxicity induced by in vitro antibody coated target cells. Cell Immunol 1972; 4: 1.
248. Escobar MR, Sigel MM. Effects of lymphoid cells and serum on target cells in xenogeneic cell-culture systems. Proc Soc Exp Biol Med 1970; 134: 744.
249. Grani CK, Avis PJ, Hali JG, Alexander P. Evidence for the role of antibody in the cytotoxic action of lymph cells on xenogeneic target cells. Transplantation 1971; 11: 356.
250. Bailey LL, Nehlsen-Cannarella SL. Observations on cardiac xenotransplantation. Transplant Proc 1986; 18: 88.
251. Ertel W, Reichenspurner H, Hammer C, et al. Heart transplantation in closely related species: a model for humoral rejection. Transplant Proc 1985; 16: 1259.
252. Perper RJ, Merkel FK, Najarian JS. Prolongation of renal xenograft survival. JAMA 1968; 204: 531.
253. Jeannet M, Pinn VW, Flax MH, Winn HJ, Russell PS. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970; 282: 111.
254. Muller-Rucholtz W, Muller-Hermelink HK, Wotage HU. Induction of lasting hematopoietic chimerism in a xenogeneic (rat to mouse) model. Transplant Proc 1979; 11: 517.
255. Bau J, Thierfelder S. Antilymphocytic antibodies and marrow transplantation: the effect of antilymphocyte serum on xenogeneic engraftment. Transplantation 1973; 15: 564.
256. Trentin JJ, Rauchwerger JM, Ballagher MT. Genetic resistance to marrow transplantation. Biomedicine 1973; 18: 109.
257. Rauchwerger JM, Ballagher MT, Trentin JJ. Xenogeneic resistance to rat bone marrow transplantation: II. Relationship of hemopoietic regeneration and survival. Biomedicine 1973; 18: 109.
258. Ildstad ST, Russell PS, Chase CM, Sachs DH. Mixed xenogeneic bone marrow transplantation (F344 rat to B10 mouse into B10 mouse) results in long-term survival of F344 cardiac grafts across species barrier. Surg Forum 1985; 36: 363.
259. van Bekkum DW. Radiation chimeras. Transplant Proc 1970; 2: 479.
260. Gengozian N. Transplantation of rat bone marrow in irradiated mice: effect of exposure rate. Science 1964; 146: 663.
261. van Bekkum DW. A new heterologous radiation chimera. Nature 1964; 202: 1311.
262. Roller PC, Davies AJS, Doak SMA. Adv Cancer Res 1961; 6:181.
263. Santos GW, Garber RM, Cole LJ. Acceptance of rat and mouse lung grafts by radiation chimeras. JNCI 1960; 24: 1367.
264. Zaalberg OB, van Bekkum DW. Continued proliferation of transplanted rat lymphoid cells in irradiated mice. Transplant Bull 1959; 6: 91.
265. Shekarchi Ic, Makinodan T. Persistence of heterologous bone marrow in mice as a function of x-ray dose. Proc Soc Exp Biol Med 1959; 100: 414.
266. Gengozian N, Makinodan T, Congdon CC, Owen RE. The immune status of long-term survivors of lethally x-irradiated mice protected with isologous, homologous, or heterologous bone marrow. Proc Natl Acad Sci USA 1958; 44: 560.
267. Santos GW, Cole LJ. Effects of donor and host lymphoid and myeloid tissue injections in lethally x-irradiated mice treated with rat bone marrow. JNCI 1958; 21: 279.
268. Santos GW, Cole LJ, Roan PL. Effect of x-ray dose on the protective action and persistence of rat bone marrow in irradiated penicillin-treated mice. Am J Physiol 1958; 194: 23.
269. Zoalberg OB, Vos O, van Bekkum DW. Surviving rat skin grafts in mice. Nature 1957; 180: 238.
270. Congdon CC, Makinodan T, Gengozian N. Effect of injection of rat bone marrow on reticular tissues of mice exposed to x- irradiation in the midlethal dose range. JNCI 1957; 18: 603.
271. van Bekkum DW, Vos O. Immunologic aspects of homo- and heterologous bone marrow transplantation in irradiated animals. J Cell Comp Physiol 1957; 50(suppl 1): 139.
272. Gengozian N, Makinodan T. Mortality of mice as affected by variation of the x-ray dose and number of nucleated rat bone marrow cells injected. Cancer Res 1957; 17: 970.
273. Urso P, Congdon CC. The effect of the amount of isologous bone marrow injected on the recovery of hematopoietic organs, survival and body weight after lethal irradiation injury in mice. Blood 1957; 12: 251.
274. Trentin JJ. Mortality and skin transplantability in x-irradiated mice receiving isologous, homologous or heterologous bone marrow. Proc Soc Exp Biol Med 1956; 92: 688.
275. Makinodan T. Circulating rat cells in lethally irradiated mice protected with rat bone marrow. Proc Soc Exp Biol Med 1956; 92: 174.
276. Jacobson LO, Marks EK, Gaston EO. Modification of radiation injury in the rabbit. Proc Soc Exp Biol Med 1956; 91: 135.
277. Ford CE, Hamerton JL, Barnes DW, Loutit JF. Cytological identification of radiation chimeras. Nature 1956; 177: 452.
278. Gengozian N, Makinodan T. Antibody response of lethally x- irradiated mice treated with rat bone marrow. J Immunol 1956; 77: 430.
279. Nowell PC, Cole LJ, Habermeyer JG, Roan PL. Growth and continued function of rat marrow cells in x-irradiated mice. Cancer Res 1956; 16: 258.
280. Cole LJ, Habermeyer JG, Bond VP. Recovery from acute radiation injury in mice following administration of rat bone marrow. JNCI 1955; 16: 1.
281. Fishier MC, Cole LJ, Bone VP, Milne WL. Therapeutic effect of rat bone marrow injection in rats exposed to lethal whole-body x-irradiation. Am J Physiol 1954; 177: 236.
282. Congdon CC, Lorenz E. Humoral factor in irradiation protection: modification of lethal irradiation injury in mice by injection of rat bone marrow. Am J Physiol 1954; 176: 297.
283. Ildstad ST, Wren SM, Sharrow SO, Stephany D, Sachs DH. In vivo and in vitro characterization of specific hyporeactivity to skin xenografts in mixed xenogeneically reconstituted mice (B10+F344 rat to B10). J Exp Med 1984; 160: 1820.
284. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168.
285. Gengozian N, Carlson DE, Allen EM. Transplantation of allogeneic and xenogeneic (rat) marrow in irradiated mice as affected by radiation exposure ratio. Transplantation 1969; 7: 259.
286. Gengozian N, Congdon CL. Effect of syngeneic antilymphocyte serum on rat-mouse radiation chimeras. Transplant Proc 1969; 1: 34.
287. Buchsbaum HJ, Aliminosa KV, Southam CM. Prolonged survival of human skin grafts in immunologically tolerant rats. Transplantation 1969; 8: 901.
288. Cerilli GJ, Gideon L. Successful long term inhibition of xenograft rejection. Surg Forum 1969; 20: 284.
289. Lance EM, Levey RH, Medawar PB, Ruszkiewicz M. Tolerance of rat skin grafts in adult mice. Proc Natl Acad Sci USA 1969; 64:1356.
290. Reilly RW, Woodruff MFA. Induction of tolerance of rat skin in newborn mice. Transplant Bull 1961; 28: 39.
291. Hasek M, Hraba T, Hort J. Acquired immunological tolerance of heterografts. Nature 1959; 183:1199.
292. Mitchison NA. The results of transplantation of turkey spleen and blood cells into chicken embryos. Transplant Bull 1958; 5: 66.
293. Egdahl RH, Roller FR, Swanson RL, Varco RL. Acquired tolerance to homografts and heterografts in the rat. Ann NY Acad Sci 1958; 73: 842.
294. Egdahl RH, Good RA, Varco RL. Studies in homograft and heterograft survival. Surgery 1957; 42: 228.
295. Hasek M, Hort J. Mechanisms of immunological tolerance. Prague: Czech Acad Sci 1962: 143.
296. Egdahl RH, Roller RR, Svanson RL, Varco RL. Acquired tolerance to homografts and heterografts in the rat. Ann NY Acad Sci 1959; 73: 842.
297. Simonsen M. Artificial production of immunological tolerance: induced tolerance to heterologous cells and induced susceptibility to virus. Nature 1955; 175: 763.
298. Chernyakhovskaya IY, Lyadova IV. Delayed-type hypersensitivity to transplantation antigens in mice and its investigation under conditions of allograft and xenograft tolerance. Folia Biol (Praha) 1987; 33: 166.
299. Pickering DE, Sussman HH. Renal function studies in monkeys. Am J Vet Res 1962; 23: 667.
300. Gagnon JA, Clarke RW. Renal functions in the chimpanzee. Am J Physiol 1957; 190: 117.
301. Smith HW, Clarke RW. The excretion of inulin and creatinine by the anthropoid apes and other infra human species. Am J Physiol 1938; 122: 132.
302. Bibler DD, Condon RE, Nyhus LM. Effect of heterologous liver perfusion on dogs in experimental hepatic insufficiency. Surg Forum 1965; 16: 286.
303. Woolnough JA, Misko IS, Lafferty KJ. Cytotoxic and proliferative response to allogeneic and xenogeneic antigens in vitro. Aust J Exp Biol Med Sci 1979; 57: 467.
304. Asantila T, Vahala J, Toivanen P. Response of human fetal lymphocytes in xenogeneic mixed lymphocyte culture: phylo- genetic and ontogenetic aspects. Immunogenetics 1974; 3: 272.
305. Hersh EM. Blastogenic responses of human lymphocytes to xenogeneic cells in vitro. Transplantation 1971; 12: 287.
306. Wilson DB, Fox DH. Quantitative studies on the mixed lymphocyte interaction in rats: VI. Reactivity of lymphocytes from conventional and germfree rats to allogeneic and xenogeneic cell surface antigens. J Exp Med 1971; 134: 857.
307. Wilson DB, Nowell PC. Quantitative studies on the mixed lymphocyte interaction in rats: IV. Immunological potentiality of the responding cells. J Exp Med 1970; 131: 391.
308. Lafferty KJ, Jones MAS. Reactions of the graft-versus-host (GVH) type. Aust J Exp Biol Med Sci 1969; 47: 17.
309. Greineder DK, Rosenthal AS. Macrophage activation of allogeneic lymphocyte proliferation in the guinea pig mixed leukocyte culture. J Immunol 1975; 114: 1541.
310. Yoshizawa K, Yano A. Mouse T lymphocytes proliferative responses for human MHC products in mouse anti-human xenogeneic MLR. J Immunol 1984; 132: 2820.
311. Swain SL, Dutton RW, Schwab R, Yamamoto J. Xenogeneic human anti-mouse T cell responses are due to the activity of the same functional T cell subsets responsible for allospecific and major histocompatibility complex-restricted responses. J Exp Med 1983; 157: 720.
312. Peck AB, Alter BJ, Lindahl KF. Specificity in T cell mediated lympholysis: identical genetic control of the proliferative and effector phases of allogeneic and xenogeneic reactions. Transplant Rev 1976; 29: 189.
313. Lindahl KF, Bach FH. Genetic and cellular aspects of xenogeneic mixed lymphocyte culture reaction. J Exp Med 1976; 144: 305.
314. Shons AR, Najarian JS. Xenograft rejection in human beings. Rev Surg 1975; 32: 70.
315. Hirshberg H, Rankin B, Thorsby E. Specificity of human lymphocytes proliferating in response to allogeneic and xenogeneic cells in vitro. Transplantation 1974; 17: 593.
316. Shons AR, Kromrey C, Najarian JS. Xenogeneic mixed lymphocyte response. Cell Immunol 1973; 6: 420.
317. Bach FH, Engstrom MA, Bach ML, Sell KW. Histocompatibility matching: VII. Mixed leukocyte cultures between chimpanzee and man. Transplant Proc 1972; 4: 97.
318. Nielsen HE. Reactivity of lymphocytes from germfree rats in mixed leukocyte culture and in graft-versus-host reaction. J Exp Med 1972; 136: 417.
319. Widmer MB, Sondel PM, Bach FH. Responsiveness of germfree mice in mixed leukocyte culture: re-examining the nature of the responding unit. J Exp Med 1972; 136: 398.
320. Widmer MB, Bach FH. Allogeneic and xenogeneic response in mixed leukocyte cultures. J Exp Med 1972; 135: 1204.
321. Knight SC, Thorbecke GJ. Ontogeny of cellular immunity: development in rat thymocytes of mixed lymphocyte reactivity to allogeneic and xenogeneic cells. Cell Immunol 1971; 2: 91.
322. Harris JE, Hersh EM, Huggins S. Human immune response to a xenogeneic nucleated cell. Transplantation 1970; 9: 440.
323. Rudolph RH, Hered B, Epstein RB, Thomas ED. Canine mixed leukocyte reactivity and transplantation antigens. Transplantation 1969; 8: 141.
324. Stejskal V, Holm G, Perlmann P. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. I. Activation by tuberculin and staphylococcus filtrate. Cell Immunol 1973; 8: 71.
325. Burakoff SJ, Ratnofsky SE, Benacerraf B. Mouse cytolytic T lymphocytes induced by xenogeneic rat stimulator cells exhibit specificity for H-2 complex antigens. Proc Natl Acad Sci USA 1977; 74: 4572.
326. Greenstein JL, Foran JA, Gorga JC, Burakoff SJ. The role of T cell accessory molecules in the generation of class II specific xenogeneic cytolytic T cells. J Immunol 1986; 136: 2358.
327. Mentzer SJ, Barbosa JA, Strominger JL, Biro PA, Burakoff SJ. Species-restricted recognition of transfected HLA-A2 and HLA- B7 by human CTL clones. J Immunol 1986; 137: 408.
328. Engelhard VH, Powers GA, Moore LC, Hotterman MJ, Correa- Freire MC. Cytotoxic T lymphocyte recognition of HLA-A/B antigens introduced into EL-4 cells by cell-liposome fusion. J Immunol 1984; 132: 76.
329. Engelhard VH, Benjamin C. Isolation and characterization of monoclonal mouse cytotoxic T lymphocytes with specificity for HLA A, B, or DR alloantigens. J Immunol 1982; 129: 2621.
330. Engelhard VH, Kaufman JF, Strominger JL, Burakoff SJ. Specificity of mouse cytoxic T lymphocytes stimulated with either HLA-A and -B or HLA-DR antigens reconstituted into phospholipid vesicles. J Exp Med 1980; 152: 54S.
331. Roller TD, Clayberger C, Maryanski JL, Krensky AM. Human allospecific cytolytic T lymphocyte lysis of a murine cell transfected with HLA-A2. J Immunol 1987; 138: 2044.
332. Golding H, Bluestone J, Satz ML, Singer D, Singer A. Generation of primary murine CTL specific for allogeneic and xenogeneic MHC determinants upon stimulation with murine L cells transfected with class I genes. J Immunol 1985; 134: 3557.
333. Engelhard VH, Strominger JL, Mescher M, Burakoff SJ. Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles. Proc Natl Acad Sci USA 1978; 75: 5688.
334. Lindahl RF, Bach FH. Human lymphocytes recognize mouse alloantigens. Nature 1975; 254: 607.
335. Berke G, Clark WR, Feldman M. In vitro induction of heterograft reaction: immunological parameters of the sensitization of rat lymphocytes against mouse cells in vitro. Transplantation 1971; 12: 237.
336. Berke G, Ax W, Ginsburg H, Feldman M. Graft reaction in tissue culture: II. Quantification of the lytic action on mouse fibroblasts by rat lymphocytes sensitized on murine embryo monolayers. Immunology 1969; 16: 643.
337. Ginsburg H. Graft versus host reaction in tissue culture: I. Lysis of monolayers of embryo mouse cells from strains differing in the H-2 histocompatibility locus by rat lymphocytes sensitized in vitro. Immunology 1968; 14: 621.
338. Engelhard VH, Benjamin C. Xenogeneic cytotoxic T-cell clones recognize alloantigenic determinants on HLA-A2. Immunogenetics 1983; 18: 461.
339. Lindahl RF, Bach FH. H-2 antigens in xenogeneic cytotoxicity. Scand J Immunol 1974; 3: 876.
340. Maryanski JL, Accolla RS, Jordan B. H-2 restricted recognition of cloned HLA class I gene products expressed in mouse cells. J Immunol 1986; 136: 4340.
341. Herman A, Parham P, Weissman SM, Engelhard VH. Recognition of xenogeneic cytotoxic T lymphocytes of cells expressing HLA-A2 or HLA-B7 after DNA-mediated gene transfer. Proc Natl Acad Sci USA 1983; 80: 5056.
342. Burakoff SJ, Dorf ME, Benacerraf B. Specificity of rat xenogeneic cell-mediated cytolysis for the products of the K and D loci of the mouse H-2 complex. J Immunol 1977; 118: 1795.
343. Carnaud C, Fadai-Ghotbi M, Lesavre P, Bach JF. Education of human lymphocytes against mouse cells: specific recognition of H-2 antigens. Eur J Immunol 1977; 7: 81.
344. Lindahl KF, Bach FH. Human lymphocytes recognize mouse alloantigens. Nature 1975; 254: 607.
345. Burakoff SJ, Engelhard VH, Kaufmann J, Strominger JL. Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens. Nature 1980; 283: 495.
346. Mizuochi T, Ono S, Malek TR, Singer A. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens. J Exp Med 1986; 163: 603.
347. Golding H, Mizuochi T, McCarthy SA, Cleveland CA, Singer A. Relationships among function, phenotype, and specificity in primary allospecific T cell populations: phenotypically identical but functionally distinct T cell subsets differ in their recognition of MHC class I and class II determinants. J Immunol 1987; 138: 10.
348. Barbosa JA, Mentzer SJ, Minowada G, Strominger JL, Burakoff SJ, Biro PA. Recognition of HLA-A2 and B7 antigens by cloned cytotoxic T lymphocytes after gene transfer into human and monkey, but not mouse cells. Proc Natl Acad Sci USA 1984; 81: 7549.
349. Bernabeu C, Finlay D, Van de Rijn M, et al. Expression of the major histocompatibility antigens HLA-A2 and HLA-B7 by DNA-mediated gene transfer. J Immunol 1983; 131: 2032.
350. Van de Rijn M, Bernabeu C, Poyer-Rokora B, et al. Recognition of HLA-A2 by cytotoxic T lymphocytes after DNA transfer into human and murine cells. Science 1984; 226: 1083.
351. Maryanski JL, Moretta A, Jordan B, et al. Human T cell recognition of cloned HLA class I gene products expressed on DNA transfectants of mouse mastocytoma P815. Eur J Immunol 1985; 15: 1111.
352. Cowan EP, Coligan JE, Biddison WE. Human cytotoxic T-lym- phocyte recognition of an HLA-A3 gene product expressed on murine L cells: the only human gene product required on the target cells for lysis is the class I heavy chain. Proc Natl Acad Sci USA 1985; 82: 4490.
353. Gomard E, Begue B, Sodoyer S, Maryanski JL, Jordan BR, Levy JP. Murine cells expressing an HLA molecule are specifically lysed by HLA-restricted antiviral human T cells. Nature 1986; 319: 153.
354. Barbosa JA, Mentzer SJ, Kamarck ME, et al. Gene mapping and somatic cell hybrid analysis of the role of human lyphocyte function-associated antigen-3 (LFA-3) in CTL-target cell interactions. J Immunol 1986; 136: 3085.
355. Lindahl KF, Wilson DB. Histcompatibility antigen-activated cytotoxic T lymphocytes: II. Estimates of the frequency and specificity of precursors. J Exp Med 1977; 145: 508.
356. Bradley SM, Kruisbeek AM, Singer A. Cytotoxic T lymphocyte response in allogeneic bone marrow chimeras: the chimeric host strictly dictates the self-repertoire of la-restricted T cells but not H-2K/D-restricted T cells. J Exp Med 1982; 156:1650.